105628-07-7

  • Product Name:Fasudil Hydrochloride
  • Molecular Formula:C14H18ClN3O2S
  • Purity:99%
  • Molecular Weight:327.835
Inquiry

Product Details

pd_meltingpoint:220.5°; mp 219.3° (Shirotani)

Appearance:white solid

Reliable factory customized supply Fasudil Hydrochloride 105628-07-7

  • Molecular Formula:C14H18ClN3O2S
  • Molecular Weight:327.835
  • Appearance/Colour:white solid 
  • Melting Point:220.5°; mp 219.3° (Shirotani) 
  • Boiling Point:506.2 °C at 760 mmHg 
  • Flash Point:259.9 °C 
  • PSA:70.68000 
  • LogP:4.17030 

Fasudil hydrochloride(Cas 105628-07-7) Usage

Indications and Usage

Fasudil Hydrochloride is a new drug with a wide range of pharmacological effects, developed by Asahi Kasei Corporation (Japan.) It is a cardiovascular and cerebrovascular drug which improves symptoms of ischemic cerebrovascular disease such as cerebral vasospasm following subarachnoid hemorrhage. It has significant neuroprotective and therapeutic effects for ischemic cerebrovascular disease, and is suited for clinical use, particularly at the grassroots level to reduce mortality and improve quality of life.

Mechanisms of Action

Fasudil Hydrochloride is an isoquinoline sulfonamide derivative which can relax separated cerebral blood vessels, inhibit the shrinkage of separated blood vessels caused by calcium influx, inhibit different mechanisms of brain blood vessel contraction from contractile agents, and inhibit intracellular calcium ion activity without reducing calcium ion concentration. Fasudil Hydrochloride is an RHO kinase inhibitor which dilates vessels, reduces tension of endothelial cells, and improves microcirculation of brain tissue without producing or exacerbating diversion of blood to the brain, by increasing activity of myosin light chain phosphatase. At the same time, it can protect nerves against apoptosis and promote their regeneration. Fasudil Hydrochloride promotes recovery of neural function and reduces clinical symptoms.

Adverse reactions

Adverse reactions after use can include intracranial hemorrhage, gastrointestinal bleeding, pulmonary hemorrhage, nasal bleeding, subcutaneous bleeding, and loss of consciousness, etc., as well as abnormal liver function. Low blood pressure, anemia, leukopenia, renal dysfunction, polyuria, rashes, and fever, etc. occur occasionally.

Warnings and Precautions

Patients with intracranial hemorrhage or possibility thereof, or low blood pressure, should not use. Patients with diabetes mellitus, cerebral arterial sclerosis, severe disturbance of consciousness, subarachnoid hemorrhages with cerebrovascular disorders, and liver or kidney dysfunction, or those over 70 years old, pregnant, or children should use with caution. Breastfeeding women should stop while using the drug. Fasudil Hydrochloride can only be administered via intravenous drip.

Brand name

Eril

InChI:InChI=1/C14H17N3O2S.ClH/c18-20(19,17-9-2-6-15-8-10-17)14-4-1-3-12-11-16-7-5-13(12)14;/h1,3-5,7,11,15H,2,6,8-10H2;1H

105628-07-7 Relevant articles

Unconventional Synthetic Process of Fasudil Hydrochloride: Costly Homopiperazine Was Avoided

Niu, Jinming,Wang, Dingding,Wu, Weiting,Yang, Wu-Lin,Zhao, Jianhong

, (2021/12/06)

An efficient, robust, and cost-effective...

Preparation method of compound fasudil hydrochloride

-

, (2021/09/11)

The invention relates to a novel efficie...

Preparation method of fasudil hydrochloride

-

Paragraph 0032-0049, (2020/07/13)

The invention belongs to the technical f...

Method for preparing isoquinoline hydrochloride intermediate and Rho kinase inhibitor by using BTC/Ph3PO chlorination system

-

Paragraph 0112-0127, (2020/11/23)

The invention discloses a method for pre...

105628-07-7 Process route

1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

isoquinoline-5-sulfonic acid
27655-40-9

isoquinoline-5-sulfonic acid

1-chloro-3,5-dimethoxybenzene
7051-16-3

1-chloro-3,5-dimethoxybenzene

fasudil hydrochloride
105628-07-7,133337-43-6,203911-27-7

fasudil hydrochloride

Conditions
Conditions Yield
isoquinoline-5-sulfonic acid; 1-chloro-3,5-dimethoxybenzene; With 4-methyl-morpholine; In chloroform; at 10 ℃; for 4h; Reflux;
1,4-Diazacycloheptane; In chloroform; at 30 ℃; for 3.5h; Reagent/catalyst; Solvent; Further stages; Reflux;
84.4%
fasudil
103745-39-7

fasudil

fasudil hydrochloride
105628-07-7,133337-43-6,203911-27-7

fasudil hydrochloride

Conditions
Conditions Yield
With hydrogenchloride; pyrographite; In methanol; water; at 30 ℃; pH=4.5 - 5;
34.9%

105628-07-7 Upstream products

  • 505-66-8
    505-66-8

    1,4-Diazacycloheptane

  • 84468-15-5
    84468-15-5

    5-isoquinolinesulfonyl chloride

  • 103745-39-7
    103745-39-7

    fasudil

  • 27655-40-9
    27655-40-9

    isoquinoline-5-sulfonic acid

105628-07-7 Downstream products

  • 103745-39-7
    103745-39-7

    fasudil

Relevant Products